Excitotoxicity and Selective Neuronal Loss in Epilepsy

Brain Pathology

Volumn 3, Issue 4, 1993, Pages 405-412

  Meldrum, Brian S ^a  

^a Institute of Forensic Psychiatry   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; EXCITOTOXIN; GLUTAMIC ACID;

BRAIN INJURY; CONFERENCE PAPER; EPILEPSY; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS;

ANIMAL; CELL DEATH; EPILEPSY; HUMAN; NEURONS;

EID: 0027527126     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.1993.tb00768.x     Document Type: Conference Paper

References (83)

1. Erkrankung des Ammonshornes als aetiologisches Moment der Epilepsie
2. Beobachtungen uber Schrumpfung und Slerose des Ammonshorn bei Epilepsie
3. The role of epileptic activity in hippocampal and “remote” cerebral lesions induced by kainic acid
4. Focal cortical seizures cause distant thalamic lesions
5. Systemic factors and epileptic brain damage. Prolonged seizures in paralysed artificially ventilated baboons
6. Epilepsy
7. Metabolic effects of prolonged epileptic seizures and the causation of epileptic brain damage
8. Seizures produced by pilocarpine: Neuropathological sequelae and activity of glutamate decarboxylase in the rat forebrain
9. An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid
10. Status epilepticus in well‐oxygenated rats causes neuronal necrosis
11. Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy
12. The neuropathology of status epilepticus
13. Neuronal lesions in mercaptopropionic acid‐induced status epilepticus
14. Consequences and prognosis of convulsive status epilepticus in infants and children
15. A pneumo‐encephalographic demonstration of brain atrophy following status epilepticus
16. Sustained electrical stimulation of the perforant path duplicates kainate‐induced electrophysiological effects and hippocampal damage in rats
17. “Epileptic” brain damage in‐rats induced by sustained electrical stimulation of the perforant path. I. Acute electrophysiological and light microscopic studies
18. Decreased hippocampal inhibition and a selective loss of interneurons in experimental epilepsy
19. Selective neuronal death in the contralateral hippocampus following unilateral kainate injections into the CA3 subfield
20. A physiological study of epileptic seizures following cortical stimulation in animals and its application to human clinics
21. Anti‐epileptic effects of focal micro‐injection of excitatory amino acid antagonists
22. 2‐amino‐7‐phosphonoheptanoic acid (2‐APH) infusion into entopeduncular nucleus protects against limbic seizures in rats
23. Excitatory neurotransmission within substantia nigra pars reticulata regulates threshold for seizures produced by pilocarpine in rats: Effects of intranigral 2‐amino–7‐phos‐phonoheptanoate and N‐methyl‐D‐aspartate
24. Glutamate‐induced neuronal necrosis in the infant mouse hypothalamus: An electron microscopic study
25. Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system
26. Excitotoxins: An overview
27. Correlation of aspartate dose, plasma dicarboxylic amino acid concentration and neuronal necrosis in infant mice
28. Excitotoxic cell death
29. Early changes in the rat hippocampus following seizures induced by bicu‐culline or L‐allylgiycine: A light and electron microscope study
30. Excitatory amino acid neurotoxicity and neurodegenerative disease
31. Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders
32. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures
33. Ketamine, phencyclidine, and MK‐801 protect against kainic acid‐induced seizure‐related brain damage
34. Ketamine and MK‐801 prevent degeneration of thalamic neurons induced by focal cortical seizures
35. Potentiation of kainic acid epileptogenicity and sparing from neuronal damage by an NMDA receptor antagonist
36. Alterations in hippocampal extracellular amino acids and purine catabolites during limbic seizures induced by folate injections into the rabbit amygdala
37. Effect of status epilepticus on extracellular amino acids in the hippocampus
38. Changes in rat brain extracellular glutamate concentration during seizures induced by systemic picrotoxin or focal bicuculline injection: An in vivo dialysis study with on‐line enzymatic detection
39. Extracellular amino acid levels in hippocampus during pilocarpine‐induced seizures
40. High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes
41. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins, and lipoxygenase reaction products in the brain during experimental epilepsy
42. Release of EAA: Animal studies and epileptic foci studies in human
43. Seizure related elevations of extracellular amino acids in human focal epilepsy
44. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain
45. NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures
46. 28K and paralbumin immunocytochemistry: Localization in the rat hippocampus with specific reference to the selective vulnerability of hippocampal neurons to seizure activity
47. 28K) and parvalbumin immunocytochemistry in the normal and epileptic human hippocampus
48. The distribution of chromogranin A‐like immunoreactivity in the human hippocampus coincides with the pattern of resistance to epilepsy‐induced neuronal damage
49. Pattern of neuronal death in the rat hippocampus after status epilepticus. Relationship to calcium binding protein content and ischemic vulnerability
50. 28K in cultured hippocampal neurons
51. Calcium‐binding proteins in the dentate gyrus
52. Kainic acid seizures and the reversibility of calcium loading in vulnerable neurons hippocampus
53. Intracellular calcium accumulation in rat hippocampus during seizures induced by bicuculline or L‐allylglycine
54. Status epilepticus: The reversibility of calcium loading and acute neuronal pathological changes in the rat hippocampus
55. GABAergic neurons are spared after intrahippocampal kainate in the rat
56. Inhibition in kainate‐lesioned hyperexcitable hippocampi: Physiologic, autoradiographic, and immunocytochemical observations
57. GABA neurons in seizure disorders: A review of immunocytochemical studies
58. Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition
59. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat: The “dormant basket cell” hypothesis and its possible relevance to temporal lobe epilepsy
60. Amino‐oxyacetic acid results in excito‐toxin lesions by a novel indirect mechanism
61. Contributory mechanisms in the causation of neurodegenerative disorders
62. Neurotoxicity at the N‐methyl‐D‐aspartate receptor in energy‐compromised neurons: An hypothesis for cell death in aging and disease
63. Glutamate becomes neurotoxic via the N‐methyl‐D‐aspartate receptor when intracellular energy levels are reduced
64. Blockade of N‐methyl‐D‐aspartate receptors prevents cyanide‐induced neuronal injury in primary hippocampal cultures
65. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses
66. 3‐Nitropropionic acid‐ exogenous animal neurotoxin and possible human striatal toxin
67. Neurochemical substrates of ictal behaviour
68. Epileptic brain damage in adolescent baboons following seizures induced by allylglycine
69. Research on the anatomy and pathology of epileptic tissue
70. Epilepsy and neuron loss in the hippocampus
71. Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas
72. Prolonged increases in neurotrophic activity associated with kainate‐induced hippocampal synaptic reorganiszation
73. Progressive neuronal loss induced by kindling: A possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis
74. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development
75. The giutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain
76. Differential ontogenic development of three receptors comprising the NMDA receptor/channel complex in the rat hippocampus
77. Neurotoxicity of N‐methyl‐D‐aspartate is markedly enhanced in developing rat central nervous system
78. Susceptibility of brain to AM PA induced excitotoxicity transiently peaks during early postnatal development
79. Maturation of kainic acid seizure‐brain damage syndrome in the rat. II. Histopathological sequelae
80. sensitivity of the developing rat brain to hypobaric/ischemic damage parallels sensitivity to N‐Methyl‐aspartate neurotoxicity
81. The susceptibility of rats to pilocarpine‐induced seizures is age‐dependent
82. At what age is the developing cerebral cortex of the rat comparable to that of the full‐term newborn human baby
83. Hippocampal neuron loss in temporal lobe epilepsy: Correlation with early childhood convulsions